Methods of inducing an HIV specific response using a Vpr-specific epitope
US6974574B2 · kind B2 · utility
4Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2002 |
| Grant date | Dec 13, 2005 |
| Priority date | — |
| Expiry date | Aug 16, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features an immunogenic composition containing a frequently-recognized epitope of an HIV-1 accessory protein such as Vpr and methods of inducing an immune response using such an epitope. The epitope peptide contains the amino acid sequence ALIRILQQL of a functionally active domain or a structural domain of the accessory protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.